LATEST PSYCHEDELICS STOCKS NEWS

Eurolife Brands Bolsters CBD Portfolio with Global Rights of CBD Food Products in 75+ Jurisdictions

Reports Significant Market Opportunity for Global Sauces, Condiments and DressingsToronto, Ontario--(Newsfile Corp. - January 23, 2020) - EuroLife Brands (CSE: EURO) (FSE: 3CMA) (OTC Pink: EURPF) ("EuroLife"), a vertically integrated enterprise focused on the pan-European hemp, cannabinoid, and health and wellness sector, is pleased to an... Read More...

Empower Clinics Announces Sun Valley Health Has Sold Its First Franchise Territory and Provides a Corporate Update

VANCOUVER, BC / ACCESSWIRE / January 23, 2020 / EMPOWER CLINICS INC. (CBDT.CN)(EPWCF)(8EC.F) ("Empower" or the "Company"), a vertically integrated and growth-oriented CBD life sciences company is pleased to announce that its Sun Valley Health division has sold it's first franchise territory in the United States.The first Sun Valley Health... Read More...

Core One Labs’ Rêveur Brand is Gaining Consumer Traction with its High Yield In-House Product

Vancouver, British Columbia--(Newsfile Corp. - January 23, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL") is pleased to see an increase in demand for Rêveur branded product being produced in its Adelanto facility.Rêveur live Resin and Indoor Flower is currently being sold through the Company's dist... Read More...

Mota Ventures Forms Research and Development Partnership with Leading Colombian University & Research Hospital

VANCOUVER, BC / ACCESSWIRE / January 23, 2020 / Mota Ventures Corp. (MOTA.CN)(FSE:1WZ:GR)(PEMTF) (the "Company") is pleased to announce that its wholly owned subsidiary Ihuana S.A.S ("Ihuana") has entered into a research cooperation agreement (the "Agreement") with La Fundacion Universitaria de Ciencias de la Salud (The University Foundat... Read More...

Empower Clinics Announces Triple Digit Patient Growth in 4Q 2019 and the Issuance of Stock Option Grants

VANCOUVER, BC / ACCESSWIRE / January 22nd, 2020 / EMPOWER CLINICS INC. (CBDT.CN)(EPWCF)(8EC.F) ("Empower" or the "Company"), a vertically integrated and growth-oriented CBD life sciences company, a multi-state operator of medical health & wellness clinics, a CBD product producer and operator of an extraction and CBD product production... Read More...

Codebase Updates Investment Focus, Announces it is Exploring New Frontier of Mushrooms and Psychedelics

VANCOUVER, BC / ACCESSWIRE / January 22nd, 2020 / Codebase Ventures Inc. ("Codebase") (CODE.CN)(C5B.F)(BKLLF), an investment company, is providing an update on its investment strategy and focus, adding a focus toward the exciting new market for mental health treatments using mushrooms and psychedelics."On behalf of shareholders, CODE is d... Read More...

Ehave Enters 88 Billion Mental Health Market

MIAMI, FL / TEL AVIV, ISRAEL / ACCESSWIRE / January 21, 2020 / Ehave, Inc., (OTC Pink:EHVVF) (the "Company"), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today that it has signed a Letter of Intent to acquire 100% of PsychedeliTech ("PsyTech"), a division of Tel Aviv, Israe... Read More...

Core One Labs Appoints Patrick Morris as Director

Vancouver, British Columbia--(Newsfile Corp. - January 21, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL") is pleased to announce the appointment of Patrick Morris as an independent director of the Company.Mr. Morris is an entrepreneur and capital market executive with over 15 years of experience, r... Read More...

YIELD GROWTH Subsidiary Flourish Mushroom Labs Signs LOI to Purchase Interest in Translational Life Sciences Inc.

Vancouver, British Columbia--(Newsfile Corp. - January 21, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces its subsidiary Flourish Mushroom Labs Inc. has entered into an agreement to acquire approximately 18% of the outstanding stock of Translational Life Sciences Inc. ("TLS").Flourish Mushroom LabsTo view a... Read More...

Revive Therapeutics Provides Update on its Cannabinoid Program Initiatives for Drug Delivery and in the Prevention of Ischemia and Reperfusion Injury from Organ Transplantation

TORONTO, Jan. 20, 2020 -- Revive Therapeutics Ltd. (“Revive” and the “Company”) (CSE:RVV), a cannabis life sciences company focused on novel cannabinoid-based treatments for rare inflammatory diseases, is pleased to provide an update, further to the Company’s announcement on January 6, 2020 regarding its clinical development plan on liver... Read More...

Greenstar Biosciences Announces Grant of Stock Options

Vancouver, British Columbia--(Newsfile Corp. - January 17, 2020) -  GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), announces it has granted stock options to acquire a total of 1,900,000 common shares of the Company to certain officers, directors and consultants of the Company. The options are exe... Read More...

Graph Blockchain Appoints Matt Humphreys to the Board

TORONTO, Jan. 16, 2020 -- Graph Blockchain Inc. ("Graph" or "Company") (CSE: GBLC) is pleased to announce the appointment of Matt Humphreys to the board of directors. In addition to being on the board, Mr. Humphreys will be advising the Company on the buildout of a blockchain based E-Commerce platform to serve the psychedelics industry.Mr... Read More...

YIELD GROWTH Subsidiary Flourish Mushroom Labs Appoints former Chairman of Johnson & Johnson, Jeff B. Smith as Chairman of the Board

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces its subsidiary Flourish Mushroom Labs Inc. has appointed Jeff B. Smith as a director and as Chairman of the Board.Jeff B. Smith, Director and Chairman of Flourish Mushroom LabsTo view an enhanced versio... Read More...

IntelGenx Receives Health Canada Authorization to Proceed with New Amendment for Montelukast VersaFilm® Phase 2a Trial

- Ongoing BUENA Trial to Continue at Increased Daily Dose -SAINT LAURENT, Quebec, Jan. 15, 2020 -- IntelGenx Corp. (IGX.V) (IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that Health Canada has issued a No Objection Letter in response to IntelGenx’s amended Clinical Trial Application (“CTA”) for the ongoing Montelu... Read More...

EuroLife Executive Team Returns to Europe to Facilitate Closure of LOI for Largest Hemp Facility in Germany

Toronto, Ontario--(Newsfile Corp. - January 14, 2020) -  EuroLife Brands (CSE: EURO) (FSE: 3CMA) (OTC Pink: EURPF) ("EuroLife"), a vertically integrated enterprise focused on the pan European hemp, cannabinoid, and health & wellness sector, is pleased to announce its return to Europe to assess opportunities in the CBD Hemp sector and ... Read More...

YIELD GROWTH Subsidiary Flourish Mushroom Labs Appoints Neurologist and Psychiatrist Dr. William Panenka as Chair of the Medical Advisory Board

Vancouver, British Columbia--(Newsfile Corp. - January 14, 2020) -  The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces its subsidiary Flourish Mushroom Labs Inc. has appointed Dr. William Panenka, MD, MSc, FRCPC (Neurology and Psychiatry) as Chair of its Medical Advisory Board.Figure 1: Neurologist and Psychiatrist Dr.... Read More...

Graph Blockchain Appoints New CEO

TORONTO, Jan. 13, 2020 -- Graph Blockchain Inc. ("Graph" or "Company") (CSE: GBLC) is pleased to announce the appointment of Govinda Butcher to CEO and Director replacing Mr. Jeff Stevens, Interim CEO and Chairman, effective immediately.Mr. Govinda Butcher has over 20 years experience in sales, recruitment, personnel development and reten... Read More...

IntelGenx Provides Commercial Update on its Two Lead VersaFilm® Product Candidates, Cannabis-Infused Oral Film and RIZAPORT®

SAINT LAURENT, Quebec, Jan. 13, 2020 -- IntelGenx Corp. (IGX.V) (IGXT) (“IntelGenx”), a leader in pharmaceutical films, today provided a commercial update on its two lead product candidates, cannabis-infused VersaFilm® and RIZAPORT®. IntelGenx is providing this information ahead of its planned participation in investment community meeting... Read More...

IntelGenx Enters Animal Health Market by Signing Feasibility Agreement for VetaFilm™ Platform

SAINT LAURENT, Quebec, Jan. 09, 2020 -- IntelGenx Corp. (IGX.V) (IGXT) (“IntelGenx”) a leader in pharmaceutical films, today announced that it has entered into a Feasibility Study Agreement (the “Agreement”) with an undisclosed partner (the “Partner”) focused on bringing innovative animal health products to the market.Pursuant to the Agre... Read More...

YIELD GROWTH Subsidiary Flourish Mushroom Labs Appoints VP, Sales with Extensive Experience Selling Mushroom Products from Market Leader

Vancouver, British Columbia--(Newsfile Corp. - January 9, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces it has appointed seasoned sales expert Amber Allen as VP, Sales for Yield Growth's Flourish Mushroom Labs Inc.Amber Allen joins Flourish Mushroom Labs Inc. as VP, SalesTo view an enhanced version of this... Read More...

YIELD GROWTH Subsidiary Flourish Mushroom Labs Announces Agreement to Establish Laboratory to Grow and Research Psilocybin Mushrooms

Vancouver, British Columbia--(Newsfile Corp. - January 7, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces its subsidiary Flourish Mushroom Labs Inc. entered into a binding letter of intent on January 4, 2020 with Acres Agricultural Canada Corp. ("Acres") to jointly form a company in Saint Vincent and the Gre... Read More...

Revive Therapeutics Provides Update on its Clinical Development Plan For Rare Liver Diseases

TORONTO, Jan. 06, 2020 -- Revive Therapeutics Ltd. (“Revive” and the “Company”) (CSE:RVV), a cannabis life sciences company focused on novel cannabinoid-based treatments for rare inflammatory diseases, is pleased to provide an update on the Company’s clinical development plan for Autoimmune liver diseases, which includes Cannabidiol in th... Read More...

Core One Labs’ Subsidiary, Core Isogenics Inc., Completes Second and Third Harvests of Top Grade Flower at the Adelanto Indoor Grow

VANCOUVER, British Columbia, Jan. 3, 2020 -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL") announces that its wholly-owned subsidiary, Core Isogenics Inc., has completed its second and third on-going harvests at the Adelanto facility.Core One Labs Inc. Logo (PRNewsfoto/Core One Labs Inc.)The second... Read More...

The Yield Growth Corp. Accelerating Global Distribution and Seizing Opportunities in Psychedelic Research

Vancouver, British Columbia--(Newsfile Corp. - January 2, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to announce increasing global distribution of its brands. Further, the company intends to become a leader in the exciting and burgeoning psychedelic medicine industry as the company continues to build i... Read More...

Nutritional High Announces Financial Results for Q1 2020 Ended Oct 31, 2019

Q1 Cannabis Sales of $6.7 million, Quarter over Quarter growth of 19%TORONTO, Dec. 31, 2019 -- Nutritional High International Inc. ("Nutritional High" or the "Company") (CSE: EAT, OTCQB: SPLIF) is pleased to announce its financial and business results for the first quarter ended October 31, 2019.Q1 2020Q4 2019ChangeQ1 2019ChangeRevenue$6,... Read More...

Listen Live: The Yield Growth Corp. to Host Live Webcast Featuring a “2020 Outlook on the Psychedelic Mushroom Boom”

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2019) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE:YG3) will host an investor conference call and webcast, on January 7th, 2020 at 1pm Eastern Standard Time, featuring a live presentation by Yield Growth CEO and Co-Founder, Penny White.Webcast: Tuesday, January 7, 202... Read More...

Nutritional High Announces Approval of the Amendment to the Unsecured Convertible Debentures Due March 14, 2021  

TORONTO, Dec. 30, 2019 -- Nutritional High International Inc. ("Nutritional High" or the "Company") (CSE: EAT, OTCQB: SPLIF) announces that the proposed amendments to the terms of the unsecured convertible debentures have been approved in accordance with the Management Information Circular dated December 3, 2019 at the meeting of the debe... Read More...

Nutritional High Announces Addition to Calyx Management Team, Cost Cuts, to Ensure Success of California Distribution Business

TORONTO, Dec. 30, 2019 -- Nutritional High International Inc. ("Nutritional High" or the "Company") (CSE: EAT, OTCQB: SPLIF) announces that following the December 10, 2019, Nutritional High announcement regarding changes to its California distribution business, Calyx Brands (“Calyx”) , the company has taken action on cost restructuring an... Read More...